Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
glp 1 agonist and dpp 4 inhibitor Frontiers The Role of DPP-4
The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
3 Although no studies have prospectively stratified patients by baseline A1C in evaluation of the A1C-lowering efficacy of a DPP-4 inhibitor or SGLT2 inhibitor, post-hoc subgroup analyses have shown that the efficacy of SGLT2 inhibitors is greater than that of DPP-4 inhibitors among patients with higher baseline A1C (≥ 8-8.5%), while patients with baseline A1C at the lower end of the spectrum ( 30 mL/min and clinical CV disease according to Diabetes Canada
The opinions expressed herein are those of the author, and do not necessarily reflect the views and opinions of Merck Canada Inc
US$ 23.92
US$ 21.89
US$ 23.32
US$ 27.54
US$ 28.89
US$ 21.66
US$ 23.64
US$ 26.00
US$ 20.90
